Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» TAK-861
TAK-861
Takeda Pushes One Narcolepsy Program into Phase III, Discontinues Another
BioSpace
Fri, 02/9/24 - 11:18 am
Takeda
clinical trials
TAK-861
narcolepsy